Mann mit Wirtschaftszeitung (Symbolbild).
Quelle: - pixabay.com:
Google
PR Newswire  | 

Sun Life Reports Fourth Quarter and Full Year 2024 Results

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Sun Life Financial Inc 50,00 € Sun Life Financial Inc Chart -0,99%
Zugehörige Wertpapiere:

The information in this document is based on the unaudited interim financial results of Sun Life Financial Inc. ("SLF Inc.") for the period ended December 31, 2024. SLF Inc., its subsidiaries and, where applicable, its joint ventures and associates are collectively referred to as "the Company", "Sun Life", "we", "our", and "us". We manage our operations and report our financial results in five business segments: Asset Management, Canada, United States ("U.S."), Asia, and Corporate. Reported net income (loss) refers to Common shareholders' net income (loss) determined in accordance with International Financial Reporting Standards ("IFRS"). Unless otherwise noted, all amounts are in Canadian dollars. Amounts in this document may be impacted by rounding. Certain 2023 results in the Drivers of Earnings and Contractual Service Margin ("CSM") Movement Analysis were refined to more accurately reflect how the business is managed.

Sun Life logo (CNW Group/Sun Life Financial Inc.)

TORONTO, Feb. 12, 2025 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) announced its results for the fourth quarter and full year ended December 31, 2024.

  • Underlying net income(1) of $965 million decreased $18 million or 2% from Q4'23 (full year - $3,856 million increased $128 million or 3% from 2023); underlying ROE(1) was 16.5% (full year - 17.2%).
    • Wealth & asset management underlying net income(1): $486 million, up $47 million or 11% (full year - $1,823 million, up $97 million or 6%).
    • Group - Health & Protection underlying net income(1): $266 million, down $99 million or 27% (full year - $1,196 million, down $117 million or 9%).
    • Individual - Protection underlying net income(1): $339 million, up $55 million or 19% (full year - $1,270 million, up $133 million or 12%).
    • Corporate expenses & other(1): $(126) million net loss, an increase of $(21) million in net loss or 20% (full year - $(433) million net loss, an improvement of $15 million in net loss or 3%).
  • Reported net income of $237 million decreased $512 million or 68% from Q4'23 (full year - $3,049 million decreased $37 million or 1% from 2023); reported ROE(1) was 4.0% (full year - 13.6%).
  • Assets under management ("AUM")(1) of $1,542 billion increased $142 billion or 10% from December 31, 2023.

"In 2024 Sun Life achieved strong underlying net income in Asia and Canada, growing 17 percent and six percent over last year, respectively. We also experienced solid growth in Individual Protection with a 20 percent increase in sales over last year, and an 18 percent increase in new business CSM. SLC Management recognized strong net inflows and capital raising throughout the year with a 33 percent increase in net inflows over last year, and capital raising of $24 billion," said Kevin Strain, President and CEO of Sun Life.

"In the fourth quarter we saw sustained momentum in our Asia business. Our reported net income was affected by market conditions and an impairment in our Vietnam business. Our U.S. business faced some industry-related challenges resulting in unfavourable morbidity experience in medical stop-loss, while we saw improvements in underlying results in our U.S. dental business. Our capital position remains strong with a LICAT ratio of 152 percent at SLF, and we remain confident that our steadfast focus on our Clients, coupled with our balanced and diversified business strategy, positions us well for long-term growth."

Financial and Operational Highlights



Quarterly results

Year-to-date

Profitability

Q4'24

Q4'23

2024

2023


Underlying net income ($ millions)(1)

965

983

3,856

3,728


Reported net income - Common shareholders ($ millions)

237

749

3,049

3,086


Underlying EPS ($)(1)(2)

1.68

1.68

6.66

6.36


Reported EPS ($)(2)

0.41

1.28

5.26

5.26


Underlying ROE(1)

16.5 %

18.4 %

17.2 %

17.8 %


Reported ROE(1)

4.0 %

14.0 %

13.6 %

14.7 %







Growth

Q4'24

Q4'23

2024

2023


Wealth sales & asset management gross flows ($ millions)(1)

60,999

45,750

196,074

173,820


Group - Health & Protection sales ($ millions)(1)

1,270

1,459

2,737

2,942


Individual - Protection sales ($ millions)(1)

743

707

2,983

2,491


Assets under management ("AUM") ($ billions)(1)

1,542

1,400

1,542

1,400


New business Contractual Service Margin ("CSM") ($ millions)(1)

306

381

1,473

1,253







Financial Strength

Q4'24

Q4'23




LICAT ratios (at period end)(3)






Sun Life Financial Inc.

152 %

149 %




Sun Life Assurance(4)

146 %

141 %




Financial leverage ratio (at period end)(1)(5)

20.1 %

21.5 %



_________

(1)  

Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in our Management's Discussion and Analysis ("MD&A") for the period ended December 31, 2024 ("2024 Annual MD&A").

(2)  

All earnings per share ("EPS") measures refer to fully diluted EPS, unless otherwise stated.

(3)  

Life Insurance Capital Adequacy Test ("LICAT") ratio. Our LICAT ratios are calculated in accordance with the OSFI-mandated guideline, Life Insurance Capital Adequacy Test.

(4) 

Sun Life Assurance Company of Canada ("Sun Life Assurance") is SLF Inc.'s principal operating life insurance subsidiary.

(5)  

The calculation for the financial leverage ratio includes the CSM balance (net of taxes) in the denominator. The CSM (net of taxes) was $10.3 billion as at December 31, 2024 (December 31, 2023 - $9.6 billion).

Financial and Operational Highlights - Quarterly Comparison (Q4'24 vs. Q4'23)

($ millions)

Q4'24

Underlying net income by business type(1)(2):

Sun Life

Asset
Management

Canada

U.S.

Asia

Corporate

Wealth & asset management

486

360

101

25

Group - Health & Protection

266

153

113

Individual - Protection

339

112

48

179

Corporate expenses & other

(126)

(29)

(97)

Underlying net income(1)

965

360

366

161

175

(97)

Reported net income (loss) - Common shareholders

237

326

253

(7)

11

(346)

Change in underlying net income (% year-over-year)

(2) %

9 %

5 %

(36) %

22 %

nm(3)

Change in reported net income (% year-over-year)

(68) %

10 %

(27) %

nm(3)

(75) %

nm(3)

Wealth sales & asset management gross flows(1)

60,999

54,008

4,938

2,053

Group - Health & Protection sales(1)

1,270

88

1,161

21

Individual - Protection sales(1)

743

142

601

Change in wealth sales & asset management gross flows

(% year-over-year)

33 %

41 %

(9) %

2 %

Change in group sales (% year-over-year)

(13) %

(49) %

(9) %

31 %

Change in individual sales (% year-over-year)

5 %

(17) %

12 %

(1)

Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the 2024 Annual MD&A.

(2)

For more information about the business types in Sun Life's business groups, see section A - How We Report Our Results in the 2024 Annual MD&A.

(3)

Not meaningful.

Underlying net income(1) of $965 million decreased $18 million or 2% from prior year, driven by:

  • Wealth & asset management(1) up $47 million: Higher fee income in Asset Management, Canada, and Asia, partially offset by lower net investment results in Canada.
  • Group - Health & Protection(1)(2) down $99 million: Unfavourable morbidity experience in U.S. medical stop-loss and less favourable morbidity experience in Canada, partially offset by business growth in Canada.
  • Individual - Protection(1)(2) up $55 million: Improved protection experience in Asia and Canada and higher contributions from joint ventures in Asia.
  • Corporate expenses & other(1) $(21) million increase in net loss primarily reflecting higher expenses largely from continued investments in our Asia businesses and incentive compensation in Asia.

Reported net income of $237 million decreased $512 million or 68% from prior year, driven by:

  • Lower tax-exempt investment income of $234 million in Corporate;
  • An impairment charge of $186 million on an intangible asset related to bancassurance in Vietnam reflecting updates resulting from changes in regulatory and macro-economic factors; and
  • A non-recurring provision in U.S. Dental; partially offset by
  • Market-related impacts primarily reflecting improved real estate experience(3).

Underlying ROE was 16.5% and reported ROE was 4.0% (Q4'23 - 18.4% and 14.0%, respectively). SLF Inc. ended the quarter with a LICAT ratio of 152%.

__________

(1)  

Refer to section C - Profitability in this document for more information on notable items attributable to reported and underlying net income items and the Non-IFRS Financial Measures in this document for a reconciliation between reported net income and underlying net income. For more information about the business types in Sun Life's operating segments/business groups, see section A - How We Report Our Results in the 2024 Annual MD&A.

(2)  

Effective Q1'24, reflects a refinement in the allocation methodology for expenses from Individual - Protection to Group - Health & Protection business types in the U.S. business group.

(3)  

Real estate experience reflects the difference between the actual value of real estate investments compared to management's longer-term expected returns supporting insurance contract liabilities ("real estate experience").

Business Group Highlights

Asset Management: A global leader in both public and alternative asset classes through MFS and SLC Management

Asset Management underlying net income of $360 million increased $29 million or 9% from prior year, driven by:

  • MFS(1) up $40 million (up US$25 million): Higher fee income from higher average net assets ("ANA") partially offset by higher expenses. The MFS pre-tax net operating profit margin(2) improved to 40.5% for Q4'24, compared to 39.4% in the prior year.
  • SLC Management down $11 million: Lower fee-related earnings mostly offset by higher net seed investment income. Fee-related earnings(2) decreased 14% reflecting higher expenses primarily from incentive compensation, partially offset by higher AUM driven by strong capital raising and deployment across the platform. Fee-related earnings margin(2) was 23.0% for Q4'24, compared to 24.2% in the prior year.

Reported net income of $326 million increased $29 million or 10% from prior year, driven by the increase in underlying net income.

Foreign exchange translation led to an increase of $8 million in underlying and reported net income, respectively.

Asset Management ended Q4'24 with $1,121 billion of AUM(2), consisting of $871 billion (US$606 billion) in MFS and $250 billion in SLC Management. Total Asset Management net outflows of $14.3 billion in Q4'24 reflected MFS net outflows of $28.5 billion (US$20.4 billion) primarily reflecting institutional product net outflows, partially offset by SLC Management net inflows of $14.1 billion reflecting strong capital raising and deployment across the platform.

MFS continued to experience solid fixed income flows, generating US$1.5 billion in net inflows for this asset class during the quarter, and launched five active exchange traded funds ("ETFs"), continuing to expand the diverse range of investment products offered to Clients, while also meeting the growing demand for tax-efficient products.

lnfraRed Capital Partners ("lnfraRed") closed its sixth flagship value-added infrastructure fund during the fourth quarter with over US$1 billion in capital commitments. The fund aims to generate value by creating and de-risking essential mid-market infrastructure companies and projects in the energy, digital, and transport sectors.

The SLC Management team also won the 2024 Insurance Investor North American Award for Insurance Investment Strategy of the Year, reflecting the effort, innovation, and strength of talent that defines our team and highlights our commitment to our Clients.

Canada: A leader in health, wealth, and insurance

Canada underlying net income of $366 million increased $16 million or 5% from prior year, reflecting:

  • Wealth & asset management up $9 million: Business growth and higher fee income driven by higher AUM largely offset by lower net investment results, including unfavourable credit experience.
  • Group - Health & Protection down $6 million: Business growth and higher investment results more than offset by less favourable morbidity experience reflecting higher claims volumes and longer claims durations.
  • Individual - Protection up $13 million: Favourable mortality experience driven by lower claims, and higher investment results.
  • Lower earnings on surplus across all businesses primarily reflecting lower net interest income.

Reported net income of $253 million decreased $95 million or 27% from prior year, reflecting market-related and ACMA(3) impacts. The market-related impacts were primarily from unfavourable interest rate impacts partially offset by improved real estate experience.

Canada's sales(4):

  • Wealth sales & asset management gross flows of $5 billion were down 9%, reflecting timing of defined benefit solution sales in Group Retirement Services ("GRS") and lower guaranteed product sales in Individual Wealth, partially offset by higher mutual fund sales in Individual Wealth.
  • Group - Health & Protection sales of $88 million were down 49%, reflecting higher large case sales in the prior year.
  • Individual - Protection sales of $142 million were down 17%, reflecting lower third-party sales.

____________

(1)

MFS Investment Management ("MFS").

(2)

Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the 2024 Annual MD&A.

(3)

Assumption changes and management actions ("ACMA").

(4)

Compared to the prior year.

We remain focused on building innovative health solutions, including online pharmacy services through the Lumino Health Pharmacy App, provided by Pillway and its affiliates, which offers quick and easy access to medications and pharmacist support. Registered users increased 40% from the prior quarter. Further, in October, we launched the Designed for Health report, which focuses on chronic disease in the workplace and offers new insights and strategies to support employee health.

In November, we launched a three-year partnership with Tribal Wi-Chi-Way-Win Capital Corporation ("TWCC")(1) to provide Contact Centre services for the Canadian Dental Care Plan. This partnership will double the size of TWCC's Contact Centre, bringing new employment opportunities to Manitoba. We are committed to advancing our Partnership Accreditation in Indigenous Relations certification.

U.S.: A leader in health and benefits

U.S. underlying net income of US$115 million decreased US$72 million or 39% ($161 million decreased $92 million or 36%) from prior year, driven by:

  • Group - Health & Protection(2) down US$71 million: Unfavourable morbidity experience in medical stop-loss driven by claims severity.
  • Individual - Protection(2) down US$1 million: In line with the prior year.

Reported net loss was US$1 million compared to reported net income of US$77 million in the prior year (reported net loss was $7 million compared to reported net income of $101 million in the prior year), reflecting the decrease in underlying net income and a non-recurring provision in Dental, partially offset by ACMA impacts. Unfavourable interest rate impacts were mostly offset by improved real estate experience.

Foreign exchange translation led to an increase of $4 million in underlying net income and an increase of $1 million in reported net loss.

U.S. group sales of US$830 million were down 11% ($1,161 million, down 9%), reflecting lower Dental, employee benefits and medical stop-loss sales. Dental sales primarily reflected lower Medicaid sales.

We continue to expand our capabilities and advance our strategy to help our members access the health care and coverage they need. In Health and Risk Solutions, we launched Clinical 360+, an expanded stop-loss program that gives members digital access to personalized tools and care services through one easy app in collaboration with specialized health partners. Members can now directly interact with clinicians and resources tailored to their specific health needs. Our Clinical 360+ program helps increase early care intervention and improve health outcomes for our members.

In Employee Benefits, we expanded our Healthcare Professional long-term disability coverage to provide more income protection and return-to-work support for non-physician healthcare providers. Offering competitive benefits has become a powerful tool for healthcare organizations to recruit and retain talent, while helping to mitigate the provider shortages across the U.S. healthcare system.

Asia: A regional leader focused on fast-growing markets

Asia underlying net income of $175 million increased $32 million or 22% from prior year, driven by:

  • Wealth & asset management up $9 million: Higher fee income primarily driven by higher AUM.
  • Individual - Protection up $41 million: Improved protection experience and higher contributions from joint ventures.
  • Regional office expenses & other $(18) million increased net loss reflecting continued investments in the business across the region and higher incentive compensation.

Reported net income of $11 million decreased $33 million or 75% from prior year, driven by an impairment charge on an intangible asset related to bancassurance in Vietnam reflecting updates resulting from changes in regulatory and macro-economic factors, partially offset by market-related impacts and the increase in underlying net income. The market-related impacts were primarily from favourable interest rate impacts and improved real estate experience.

Foreign exchange translation led to an increase of $4 million in underlying net income and an increase of $6 million in reported net income.

Asia's sales(3):

  • Individual sales of $601 million were up 12%, driven by higher sales in International due to a large case sale, India reflecting growth in the bancassurance and direct-to-consumer channels, and Hong Kong from growth in agency and bancassurance channels.
  • Wealth sales & asset management gross flows were in line with prior year as higher money market fund sales in the Philippines and higher Mandatory Provident Fund ("MPF") sales in Hong Kong were offset by lower fixed income fund sales in India.

New business CSM of $201 million in Q4'24 was down from $223 million in the prior year, primarily driven by business mix.

__________

(1) 

Tribal Wi-Chi-Way-Win Capital Corporation is 100% Indigenous owned by Five Manitoba Tribal Councils and several Independent Manitoba First Nations.

(2) 

Effective Q1'24, reflects a refinement in the allocation methodology for expenses from Individual - Protection to Group - Health & Protection business types in the U.S. business group.

(3)  

Compared to the prior year.

We are committed to helping our Clients achieve lifetime financial security through financial literacy initiatives across the region. In Vietnam, we launched a series of financial literacy campaigns to promote awareness of financial planning and insurance, and to empower individuals with financial knowledge, fostering a more optimistic and secure future for our Clients.

We launched MPF Navigator in Hong Kong, an innovative digital platform developed with a leading fintech partner. This tool empowers Clients with personalized retirement planning advice, real-time market insights, and convenient MPF account management. By combining advanced technology with expert guidance, we are enhancing our Clients' digital experience and helping them make informed decisions for their financial future.

Corporate

Underlying net loss was $97 million, in line with prior year's underlying net loss of $94 million

Reported net loss was $346 million compared to reported net loss of $41 million in the prior year, reflecting lower tax exempt investment income.

In 2024, Sun Life was certified as a Great Place to Work® in Canada, the U.S., Vietnam, the Philippines, Indonesia, Malaysia, Singapore, India, and Ireland. In addition, SLC Management was also named 2024 Best Places to Work in Money Management for the fifth year in a row by Pensions & Investments(1). These recognitions reflect our inclusive culture and commitment to our people. Sun Life fosters a positive work environment where we provide the resources and flexibility to support mental, physical and professional well-being, and where employees feel motivated and equipped to excel in serving our Clients.

(1)

Pensions & Investments, a global news source of money management.



Table of Contents

A

How We Report Our Results









7

B

Financial Summary









8

C

Profitability









9

D

Growth









11

E

Contractual Service Margin









13

F

Financial Strength









15

G

Performance by Business Segment









17


1. Asset Management









18


2. Canada









20


3. U.S









21


4. Asia









22


5. Corporate









23

H

Non-IFRS Financial Measures









24

I

Forward-looking Statements









30

About Sun Life

Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of December 31, 2024, Sun Life had total assets under management of $1.54 trillion. For more information, please visit www.sunlife.com.

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.

A. How We Report Our Results

Sun Life Financial Inc., its subsidiaries and, where applicable, its joint ventures and associates are collectively referred to as "the Company", "Sun Life", "we", "our", and "us". We manage our operations and report our financial results in five business segments: Asset Management, Canada, U.S., Asia, and Corporate. Information concerning these segments is included in our annual and interim consolidated financial statements and accompanying notes ("Annual Consolidated Financial Statements" and "Interim Consolidated Financial Statements", respectively, and "Consolidated Financial Statements" collectively) and interim and annual management's discussion and analysis ("MD&A"). We prepare our unaudited Interim Consolidated Financial Statements using International Financial Reporting Standards ("IFRS"), the accounting requirements of the Office of the Superintendent of Financial Institutions ("OSFI"). Reported net income (loss) refers to Common shareholders' net income (loss) determined in accordance with IFRS.

Unless otherwise noted, all amounts are in Canadian dollars. Amounts in this document are impacted by rounding. Certain 2023 results in the Drivers of Earnings and Contractual Service Margin ("CSM") Movement Analysis were refined to more accurately reflect how the business is managed.

1. Use of Non-IFRS Financial Measures

We report certain financial information using non-IFRS financial measures, as we believe that these measures provide information that is useful to investors in understanding our performance and facilitate a comparison of our quarterly and full year results from period to period. These non-IFRS financial measures do not have any standardized meaning and may not be comparable with similar measures used by other companies. For certain non-IFRS financial measures, there are no directly comparable amounts under IFRS. These non-IFRS financial measures should not be viewed in isolation from or as alternatives to measures of financial performance determined in accordance with IFRS. Additional information concerning non-IFRS financial measures and, if applicable, reconciliations to the closest IFRS measures are available in section H - Non-IFRS Financial Measures in this document, section M - Non-IFRS Financial Measures in our 2024 Annual MD&A, and the Supplementary Financial Information package on www.sunlife.com under Investors - Financial results and reports.

2. Forward-looking Statements

Certain statements in this document are forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Additional information concerning forward-looking statements and important risk factors that could cause our assumptions, estimates, expectations and projections to be inaccurate and our actual results or events to differ materially from those expressed in or implied by such forward-looking statements can be found in section I - Forward-looking Statements in this document.

3. Additional Information

Additional information about SLF Inc. can be found in the Consolidated Financial Statements, the Annual and Interim MD&A and SLF Inc.'s Annual Information Form ("AIF") for the year ended December 31, 2024. These documents are filed with securities regulators in Canada and are available at www.sedarplus.ca. SLF Inc.'s Annual Consolidated Financial Statements, Annual MD&A and AIF are filed with the United States Securities and Exchange Commission ("SEC") in SLF Inc.'s annual report on Form 40-F and SLF Inc.'s Interim MD&A and Interim Consolidated Financial Statements are furnished to the SEC on Form 6-Ks and are available at www.sec.gov.

B. Financial Summary

($ millions, unless otherwise noted)

Quarterly results

Year-to-date

Profitability

Q4'24 

Q3'24 

Q4'23 

2024

2023


Net income (loss)







Underlying net income (loss)(1)

965

1,016

983

3,856

3,728


Reported net income (loss) - Common shareholders

237

1,348

749

3,049

3,086


Diluted earnings per share ("EPS") ($)







Underlying EPS (diluted)(1)

1.68

1.76

1.68

6.66

6.36


Reported EPS (diluted)

0.41

2.33

1.28

5.26

5.26


Return on equity ("ROE") (%)







Underlying ROE(1)

16.5 %

17.9 %

18.4 %

17.2 %

17.8 %


Reported ROE(1)

4.0 %

23.8 %

14.0 %

13.6 %

14.7 %








Growth

Q4'24 

Q3'24 

Q4'23 

2024

2023


Sales







Wealth sales & asset management gross flows(1)

60,999

41,915

45,750

196,074

173,820


Group - Health & Protection sales(1)

1,270

445

1,459

2,737

2,942


Individual - Protection sales(1)

743

730

707

2,983

2,491


Total AUM ($ billions)(1)

1,542.3

1,514.6

1,399.6

1,542.3

1,399.6


New business Contractual Service Margin ("CSM")(1)

306

383

381

1,473

1,253








Financial Strength

Q4'24 

Q3'24 

Q4'23 




LICAT ratios







Sun Life Financial Inc.

152 %

152 %

149 %




Sun Life Assurance(2)

146 %

147 %

141 %




Financial leverage ratio(1)(3)

20.1 %

20.4 %

21.5 %




Book value per common share ($)

40.63

39.88

36.51




Weighted average common shares outstanding for basic EPS (millions)

575

578

584




Closing common shares outstanding (millions)

574

577

585



(1)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document.

(2)

Sun Life Assurance Company of Canada ("Sun Life Assurance") is SLF Inc.'s principal operating life insurance subsidiary.

(3)

The calculation for the financial leverage ratio includes the CSM balance (net of taxes) in the denominator. The CSM (net of taxes) was $10.3 billion as at December 31, 2024 (September 30, 2024 - $9.9 billion; December 31, 2023 - $9.6 billion).

C. Profitability

The following table reconciles our Common shareholders' net income ("reported net income") and underlying net income. All factors discussed in this document that impact underlying net income are also applicable to reported net income. Certain adjustments and notable items also impact the CSM, such as mortality experience and assumption changes; see section E - Contractual Service Margin in this document for more information.


Quarterly results

($ millions, after-tax)

Q4'24

Q3'24

Q4'23

Underlying net income (loss) by business type(1):




Wealth & asset management

486

474

439

Group - Health & Protection

266

345

365

Individual - Protection

339

306

284

Corporate expenses & other

(126)

(109)

(105)

Underlying net income(1)

965

1,016

983

   Add: 

Market-related impacts

(179)

29

(193)


Assumption changes and management actions ("ACMA")        

11

36

(1)


Other adjustments

(560)

267

(40)

Reported net income - Common shareholders

237

1,348

749

Underlying ROE(1)

16.5 %

17.9 %

18.4 %

Reported ROE(1)

4.0 %

23.8 %

14.0 %

Notable items attributable to reported and underlying net income(1):




Mortality

10

3

(5)

Morbidity

(22)

60

91

Lapse and other policyholder behaviour ("policyholder behaviour")

(5)

(11)

Expenses

(10)

(25)

(26)

Credit(2)

(34)

(61)

(18)

Other(3)

16

30

(2)

(1)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document. For more information about business types in Sun Life's business groups, see section A - How We Report Our Results in the 2024 Annual MD&A.

(2)

Credit includes rating changes on assets measured at Fair value through profit or loss ("FVTPL"), and the Expected credit loss ("ECL") impact for assets measured at Fair value through other comprehensive income ("FVOCI").

(3)

Other notable items are recorded in Net Insurance Service Result and Net Investment Result in the Drivers of Earnings analysis. For more details, see section H - Non-IFRS Financial Measures in this document.

Quarterly Comparison - Q4'24 vs. Q4'23

Underlying net income(1) of $965 million decreased $18 million or 2%, driven by:

  • Wealth & asset management(1) up $47 million: Higher fee income in Asset Management, Canada, and Asia, partially offset by lower net investment results in Canada.
  • Group - Health & Protection(1)(2) down $99 million: Unfavourable morbidity experience in U.S. medical stop-loss and less favourable morbidity experience in Canada, partially offset by business growth in Canada.
  • Individual - Protection(1)(2) up $55 million: Improved protection experience in Asia and Canada and higher contributions from joint ventures in Asia.
  • Corporate expenses & other(1) $(21) million increase in net loss primarily reflecting higher expenses largely from continued investments in our Asia businesses and incentive compensation in Asia.

Reported net income of $237 million decreased $512 million or 68%, driven by:

  • Lower tax-exempt investment income of $234 million in Corporate;
  • An impairment charge of $186 million on an intangible asset related to bancassurance in Vietnam reflecting updates resulting from changes in regulatory and macro-economic factors; and
  • A non-recurring provision in U.S. Dental; partially offset by
  • Market-related impacts primarily reflecting improved real estate experience(3).

Underlying ROE was 16.5% and reported ROE was 4.0% (Q4'23 - 18.4% and 14.0%, respectively).

1.      Market-related impacts

Market-related impacts represent the difference between actual versus expected market movements(4). Market-related impacts resulted in a decrease of $179 million to reported net income, primarily driven by interest rate impacts and real estate experience. 

2.      Assumption changes and management actions

The net impact of assumption changes and management actions was an increase of $11 million to reported net income and includes methods and assumptions changes on insurance contracts as well as related impacts. These included various small enhancements. For additional details refer to "Assumption Changes and Management Actions by Type" in section E - Contractual Service Margin in this document.

3.      Other adjustments

Other adjustments decreased reported net income $560 million, reflecting lower tax-exempt investment income in Corporate, an impairment charge on an intangible asset related to bancassurance in Vietnam reflecting updates resulting from changes in regulatory and macro-economic factors, a non-recurring provision in U.S. Dental, and DentaQuest integration costs and amortization of acquired intangible assets.

4.      Experience-related items

In the fourth quarter of 2024, notable experience items included:

    • Unfavourable morbidity experience largely in U.S. medical stop-loss, partially offset by favourable morbidity experience in Canada;
    • Unfavourable credit experience primarily in Canada; and
    • Other experience was favourable primarily from Canada.

5.   Income taxes

The statutory tax rate is impacted by various items, such as lower taxes on income subject to tax in foreign jurisdictions, tax-exempt investment income, and other sustainable tax benefits.

The Q4'24 effective income tax rate(5) on underlying net income and reported net income was 17.4% and 63.2% respectively. The effective income tax rate on reported net income reflects the non-deductible impairment charge on an intangible asset in Vietnam as well as lower tax-exempt investment income.

6.   Impacts of foreign exchange translation

Foreign exchange translation led to an increase of $16 million in underlying net income and an increase of $17 million in reported net income.

__________

(1)  

Refer to section H - Non-IFRS Financial Measures in this document for a reconciliation between reported net income and underlying net income.

(2) 

Effective Q1'24, reflects a refinement in the allocation methodology for expenses from Individual - Protection to Group - Health & Protection business types in the U.S. business group.

(3) 

Real estate experience reflects the difference between the actual value of real estate investments compared to management's longer-term expected returns supporting insurance contract liabilities ("real estate experience").

(4) 

Except for risk free rates which are based on current rates, expected market movements are based on our medium-term outlook which is reviewed annually.

(5) 

Our effective income tax rate on reported net income is calculated using Total income (loss) before income taxes, as detailed in Note 19 in our 2024 Annual Consolidated Financial Statements. Our effective income tax rate on underlying net income is calculated using pre-tax underlying net income, as detailed in section H - Non-IFRS Financial Measures in this document, and the associated income tax expense.

D. Growth

1. Sales and Gross Flows


Quarterly results

($ millions)

Q4'24

Q3'24

Q4'23

Wealth sales & asset management gross flows by business segment(1)




Asset Management gross flows

54,008

36,259

38,322

Canada wealth sales & asset management gross flows

4,938

3,755

5,424

Asia wealth sales & asset management gross flows

2,053

1,901

2,004

Total wealth sales & asset management gross flows(1)

60,999

41,915

45,750

Group - Health & Protection sales by business segment(1)




Canada

88

124

174

U.S.

1,161

300

1,269

Asia(2)

21

21

16

Total group sales(1)

1,270

445

1,459

Individual - Protection sales by business segment(1)




Canada

142

112

171

Asia

601

618

536

Total individual sales(1)

743

730

707

CSM - Impact of new insurance business ("New business CSM")(1)

306

383

381

(1)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document.

(2) 

In underlying net income by business type, Group businesses in Asia have been included with Individual - Protection. For more information about business types in Sun Life's business groups, see section A - How We Report Our Results in the 2024 Annual MD&A.

Total wealth sales & asset management gross flows increased $15.2 billion or 33% year-over-year ($13.8 billion(1) or 30%(1), excluding foreign exchange translation).

  • Asset Management gross flows increased $14.3 billion(1) or 37%(1), driven by higher gross flows in SLC Management and MFS.
  • Canada wealth sales & asset management gross flows decreased $0.5 billion or 9%, reflecting timing of defined benefit solution sales in GRS and lower guaranteed product sales in Individual Wealth, partially offset by higher mutual fund sales in Individual Wealth.
  • Asia wealth sales & asset management gross flows were in line with prior year, as higher money market fund sales in the Philippines and higher MPF sales in Hong Kong were offset by lower fixed income fund sales in India.

Total group health & protection sales decreased $189 million or 13% from prior year ($220 million(1) or 15%(1), excluding foreign exchange translation).

  • Canada group sales decreased $86 million or 49%, reflecting higher large case sales in the prior year.
  • U.S. group sales decreased $139 million(1) or 11%(1), reflecting lower Dental, employee benefits and medical stop-loss sales. Dental sales primarily reflected lower Medicaid sales.

Total individual protection sales increased $36 million or 5% from prior year ($22 million(1) or 3%(1), excluding foreign exchange translation).

  • Canada individual sales decreased $29 million or 17%, reflecting lower third-party sales.
  • Asia individual sales increased $51 million(1) or 10%(1), driven by higher sales in International due to a large case sale, India reflecting growth in the bancassurance and direct-to-consumer channels, and Hong Kong from growth in agency and bancassurance channels.

New business CSM represents growth derived from sales activity in the period. The impact of new insurance business drove a $306 million increase in CSM, compared to $381 million in the prior year, primarily driven by business mix.

_______

(1)  

This change excludes the impacts of foreign exchange translation. For more information about these non-IFRS financial measures, see section H - Non-IFRS Financial Measures in this document.

2. Assets Under Management

AUM consists of general funds, the investments for segregated fund holders ("segregated funds") and third-party assets managed by the Company. Third-party AUM is comprised of institutional and managed funds, as well as other AUM related to our joint ventures.


Quarterly results

($ millions)

Q4'24

Q3'24

Q2'24

Q1'24

Q4'23

Assets under management(1)






General fund assets

221,935

216,180

207,545

204,986

204,789

Segregated funds

148,786

145,072

136,971

135,541

128,452

Third-party assets under management(1)






Retail

648,515

633,767

607,727

606,320

567,657

Institutional, managed funds and other

568,437

562,565

553,798

563,773

537,424

Total third-party AUM(1)

1,216,952

1,196,332

1,161,525

1,170,093

1,105,081

Consolidation adjustments

(45,333)

(43,014)

(41,240)

(40,540)

(38,717)

Total assets under management(1)

1,542,340

1,514,570

1,464,801

1,470,080

1,399,605

(1)

Represents a non-IFRS financial measure. See section H - Non-IFRS Financial Measures in this document.

AUM increased $142.7 billion or 10% from December 31, 2023, primarily driven by:

(i)

favourable market movements on the value of segregated, retail, institutional and managed funds of $110.3 billion;

(ii)

an increase of $89.0 billion from foreign exchange translation (excluding the impacts of general fund assets); and

(iii)   

an increase in AUM of general fund assets of $17.1 billion primarily driven by general operating activities and favourable impacts from foreign exchange translation; partially offset by

(iv)

net outflows from segregated funds and third-party AUM of $60.7 billion;

(v)

Client distributions of $7.6 billion; and

(vi) 

a decrease of $5.4 billion from other business activities.

Segregated fund and third-party AUM net outflows of $13.6 billion during the quarter were comprised of:



($ billions)

Q4'24

Q3'24

Q2'24

Q1'24

Q4'23

Net flows for Segregated fund and Third-party AUM:






MFS

(28.5)

(19.1)

(20.2)

(11.7)

(15.3)

SLC Management

14.1

1.7

(0.7)

1.5

3.9

Canada, Asia and other

0.8

0.5

1.1

(0.3)

Total net flows for Segregated fund and Third-party AUM

(13.6)

(16.9)

(19.8)

(10.5)

(11.4)

Third-Party AUM increased by $111.9 billion or 10% from December 31, 2023, primarily driven by:

(i)       

favourable market movements of $94.9 billion; and

(ii)     

foreign exchange translation of $91.0 billion; partially offset by

(iii)   

net outflows of $61.1 billion;

(iv)   

Client distributions of $7.6 billion; and

(v)     

a decrease of $5.4 billion from other business activities.

E. Contractual Service Margin

Contractual Service Margin represents a source of stored value for future insurance profits and qualifies as available capital for LICAT purposes. CSM is a component of insurance contract liabilities. The following table shows the change in CSM including its recognition into net income in the period, as well as the growth from new insurance sales activity.


For the full year ended

For the full year ended

($ millions)

December 31, 2024

December 31, 2023

Beginning of Period

11,786

10,865

Impact of new insurance business(1)

1,473

1,253

Expected movements from asset returns & locked-in rates(1)

703

560

Insurance experience gains/losses(1)

(77)

67

CSM recognized for services provided

(1,135)

(919)

Organic CSM Movement(1)(2)

964

961

Impact of markets & other(1)

124

(38)

Impact of change in assumptions(1)

30

364

Currency impact

462

(104)

Disposition(3)

(262)

Total CSM Movement

1,580

921

Contractual Service Margin, End of Period(4)

13,366

11,786

(1)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document.

(2)

Organic CSM movement is a component of both total CSM movement and organic capital generation.

(3)

Relates to the sale of Sun Life UK. For additional information, refer to Note 3 in our 2024 Annual Consolidated Financial Statements.

(4)

Total company CSM presented above is comprised of CSM on Insurance contracts issued of $13,028 million (December 31, 2023 - $11,845 million), net of CSM Reinsurance contacts held of $(338) million (December 31, 2023 - $59 million).

Total CSM ended Q4'24 at $13.4 billion, an increase of $1.6 billion or 13% from December 31, 2023:

  • Organic CSM movement was driven by the impact of new insurance business, reflecting strong sales in Asia, primarily in Hong Kong, and Canada, primarily in individual protection.
  • Unfavourable insurance experience from Canada and Asia, partially offset by the U.S.
  • Favourable impact of markets and other driven by interest and equity experience.
  • Impact of change in assumptions include the adverse impacts of a new reinsurance treaty and lapse updates, partially offset with favourable net mortality.
  • Favourable currency impacts in Asia and the U.S.

Assumption Changes and Management Actions by Type

The impact on CSM of ACMA is attributable to insurance contracts and related impacts under the general measurement approach ("GMA") and variable fee approach ("VFA"). For insurance contracts measured under the GMA, the impacts flow through the CSM at locked-in discount rates. For insurance contracts measured under the VFA, the impact flows through the CSM at current discount rates. The following table sets out the impacts of ACMA on our reported net income and CSM for the three months ended December 31, 2024.

For the three months ended December 31, 2024


($ millions)

Reported net
income impacts
(After-tax)(1)(2)

Deferred in CSM
(Pre-tax)(2)(3)(4)

Comments

Mortality/morbidity

7

22

Minor updates to reflect mortality/morbidity experience.

Policyholder behaviour


Expense

(19)

Minor updates to reflect expense experience.

Financial

(25)

Minor updates to various financial-related assumptions.

Modelling enhancement and other

29

138

Various enhancements and methodology changes. The largest item was
a favourable refinement to Par business in International in Asia.

Total impact of change in assumptions

11

141


(1)

In this document, the reported net income impact of ACMA is shown in aggregate for Net insurance service result and Net investment result, and excludes amounts attributable to participating policyholders.

(2)

CSM is shown on a pre-tax basis as it reflects the changes in our insurance contract liabilities, while reported net income is shown on a post-tax basis to reflect the impact on capital.

(3)   

The impact of change in assumptions in the CSM rollforward of $30 million is comprised of $(23) million for the three months ended March 31, 2024, $7 million for the three months ended June 30, 2024, $(95) million for the three months ended September 30, 2024, and $141 million for the three months ended December 31, 2024, as referenced in the table above.

(4)

Total impact of change in assumptions represents a non-IFRS financial measure for amounts deferred in CSM. For more details, see section


M - Non-IFRS Financial Measures in the 2024 Annual MD&A.

F. Financial Strength

($ millions, unless otherwise stated)

Q4'24

Q3'24

Q2'24

Q1'24

Q4'23

LICAT ratio(1)






Sun Life Financial Inc.

152 %

152 %

150 %

148 %

149 %

Sun Life Assurance

146 %

147 %

142 %

142 %

141 %

Capital






Subordinated debt

6,179

6,177

6,926

6,179

6,178

Innovative capital instruments(2)

200

200

200

200

200

Equity in the participating account

496

621

567

510

457

Non-controlling interests

76

79

92

106

161

Preferred shares and other equity instruments

2,239

2,239

2,239

2,239

2,239

Common shareholders' equity(3)

23,318

22,989

21,803

21,790

21,343

Contractual Service Margin(4)

13,366

12,836

12,512

12,141

11,786

Total capital

45,874

45,141

44,339

43,165

42,364

Financial leverage ratio(4)(5)

20.1 %

20.4 %

22.6 %

21.1 %

21.5 %

Dividend






Underlying dividend payout ratio(5)

50 %

46 %

47 %

52 %

46 %

Dividends per common share ($)

0.840

0.810

0.810

0.780

0.780

Book value per common share ($)

40.63

39.88

37.70

37.41

36.51

(1)

Our LICAT ratios are calculated in accordance with the OSFI-mandated guideline, Life Insurance Capital Adequacy Test.

(2)

Innovative capital instruments consist of Sun Life ExchangEable Capital Securities ("SLEECS"), see section J - Capital and Liquidity Management in the 2024 Annual MD&A.

(3)

Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments.

(4)

The calculation for the financial leverage ratio was updated to include the CSM balance (net of taxes) in the denominator. The CSM (net of taxes) was $10.3 billion as at December 31, 2024 (September 30, 2024 - $9.9 billion; June 30, 2024 - $9.6 billion; March 31, 2024 - $9.9 billion; December 31, 2023 - $9.6 billion).

(5)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document.

1. Life Insurance Capital Adequacy Test

The Office of the Superintendent of Financial Institutions has developed the regulatory capital framework referred to as the Life Insurance Capital Adequacy Test for Canada. LICAT measures the capital adequacy of an insurer using a risk-based approach and includes elements that contribute to financial strength through periods when an insurer is under stress as well as elements that contribute to policyholder and creditor protection wind-up.

SLF Inc. is a non-operating insurance company and is subject to the LICAT guideline. Sun Life Assurance, SLF Inc.'s principal operating life insurance subsidiary, is also subject to the LICAT guideline.

SLF Inc.'s LICAT ratio of 152% as at December 31, 2024 increased three percentage points compared to December 31, 2023, driven by organic capital generation, net of shareholder dividend payments, ACMA, and market movements, partially offset by share buybacks.

Sun Life Assurance's LICAT ratio of 146% as at December 31, 2024 increased five percentage points compared to December 31, 2023, driven by organic capital generation net of dividend payments to SLF Inc., market movements, and ACMA.

The Sun Life Assurance LICAT ratios in both periods are well above OSFI's supervisory ratio of 100% and regulatory minimum ratio of 90%.

2. Capital

Our total capital consists of subordinated debt and other capital instruments, CSM, equity in the participating account and total shareholders' equity which includes common shareholders' equity, preferred shares and other equity instruments, and non-controlling interests. As at December 31, 2024, our total capital was $45.9 billion, an increase of $3.5 billion compared to December 31, 2023. The increase to total capital included reported net income of $3,049 million, an increase of $1,580 million in CSM, favourable impacts of foreign exchange translation of $1,346 million included in other comprehensive income (loss) ("OCI"), and the issuance of $750 million principal amount of Series 2024-1 Subordinated Unsecured 5.12% Fixed/Floating Debentures, which is detailed below. This was partially offset by the payment of $1,875 million of dividends on common shares of SLF Inc. ("common shares"), a decrease of $855 million from the repurchase and cancellation of common shares, which is detailed below, and the redemption of $750 million principal amount of Series 2019-1 Subordinated Unsecured 2.38% Fixed/Floating Debentures, which is detailed below.

In Q4'24, organic capital generation(1) was $350 million, which measures the change in capital, net of dividends, above LICAT requirements excluding the impacts of markets and other non-recurring items. Organic capital generation was driven by underlying net income and new business CSM.

Our capital and liquidity positions remain strong with a LICAT ratio of 152% at SLF Inc., a financial leverage ratio of 20.1%(1) and $1.4 billion in cash and other liquid assets(1) as at December 31, 2024 in SLF Inc.(2) (December 31, 2023 - $1.6 billion).

Capital Transactions

On May 15, 2024, SLF Inc. issued $750 million principal amount of Series 2024-1 Subordinated Unsecured 5.12% Fixed/Floating Debentures due 2036. An amount equal to the net proceeds from the offering of such debentures will be used to finance or refinance, in whole or in part, new and/or existing Eligible Assets as defined in our Sustainability Bond Framework dated April 2024.

On August 13, 2024, SLF Inc. redeemed all of the outstanding $750 million principal amount of Series 2019-1 Subordinated Unsecured 2.38% Fixed/Floating Debentures, in accordance with the redemption terms attached to such debentures. The redemptions were funded from existing cash and other liquid assets.

Normal Course Issuer Bids

On August 29, 2023, SLF Inc. commenced a normal course issuer bid, which was in effect until August 28, 2024 (the "2023 NCIB").

On August 26, 2024, SLF Inc. announced that OSFI and the Toronto Stock Exchange ("TSX") had approved its previously announced renewal of its normal course issuer bid to purchase up to 15 million of its common shares (the "2024 NCIB"). The 2024 NCIB commenced on August 29, 2024 and continues until August 28, 2025, or such earlier date as SLF Inc. may determine, or such date as SLF Inc. completes its purchases of common shares pursuant to the 2024 NCIB. Any common shares purchased by SLF Inc. pursuant to the 2024 NCIB will be cancelled or used in connection with certain equity settled incentive arrangements.

Shares purchased and subsequently cancelled under both bids were as follows:


Quarterly results

Year-to-date

Aggregate(1)


Q4'24

2024


Common
shares
purchased

(millions)

Amount

($ millions)(2)

Common
shares
purchased

(millions)

Amount

($ millions)(2)

Common
shares
purchased

(millions)

Amount

($ millions)(2)

2023 NCIB (expired August 28, 2024)

7.7

546

10.5

733

2024 NCIB

3.0

249

3.8

309

3.8

309

Total

3.0

249

11.5

855



(1)

Represents the balance of common shares purchased and subsequently cancelled under the life of the normal course issuer bids to-date.

(2)

Excludes the impact of excise tax on net repurchases of equity. The Government of Canada's 2023 Budget introduced a new 2% excise tax on net repurchases of equity occurring on or after January 1, 2024, and this new legislation became enacted in June 2024.

 

_____________

(1)

Represents a non-IFRS financial measure. For more details, see section H - Non-IFRS Financial Measures in this document.

(2)

SLF Inc. (the ultimate parent company) and its wholly-owned holding companies.

G. Performance by Business Segment


Quarterly results

($ millions)

Q4'24

Q3'24

Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend